NCT01550939

Brief Summary

The objectives of this study are to determine the time needed to complete a full set of measurements (Total Ophthalmic Exam, Subject Data Entry and Acquisition of the Measurement) by each test device, the Lenstar 900 Version i4 and IOL Master 500.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
61

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Jan 2012

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2012

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2012

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

March 5, 2012

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 12, 2012

Completed
Last Updated

August 1, 2012

Status Verified

July 1, 2012

Enrollment Period

2 months

First QC Date

March 5, 2012

Last Update Submit

July 31, 2012

Conditions

Keywords

Biometry of the EyeIntraocular Lens ImplantationIOL

Outcome Measures

Primary Outcomes (1)

  • Time to complete a full examination

    Time to complete a full ophthalmic exam(as measured from the time of subject placement just prior to the technician completing data entry at the test product, to the beginning of data printing) for each, the IOL Master 500 and the Haag-Streit Lenstar Version i4.

    At Study Visit (study consists of 1 visit only)

Secondary Outcomes (3)

  • Data Entry Time Measurement

    At Study Visit (study consists of 1 visit only)

  • Measurement Acquisition Time Measurement

    At Study Visit (study consists of 1 visit only)

  • Adverse Events

    Duration of study from signing informed consent to Study Visit (study consists of 1 visit only)

Study Arms (1)

Time Comparison between the Lenstar and IOLMaster

NO INTERVENTION
Device: Ophthalmic Biometer

Interventions

One complete biometry examination

Also known as: Haag-Streit Lenstar, Zeiss IOL Master 500
Time Comparison between the Lenstar and IOLMaster

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subjects wbo meet all of the following criteria are eligible to participate in tbe study:
  • Male or female l8 years of age or older on the date of Informed Consent.
  • At least one eye of each subject must be a phakic eye.
  • Subject must be able to fixate on a target.
  • Able to understand and willing to sign tbe informed consent.

You may not qualify if:

  • Subjects will be excluded from the study if the following applies:
  • History of corneal surgery.
  • Use of contact lenses during tbe ophthalmic exam or up to two hours prior to the exam.
  • Any ophthalmic condition preventing use of either of the instruments used in the study.
  • Any ophthalmic condition which might impair tbe validity of results from any of the instruments used in the study.
  • Any medical condition, which, in tbe Investigator's judgment, interferes with the subjects ability to comply with tbe protocol, compromises subject safety, or interferes with tbe interpretation of the study results.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cincinnati Eye Institute

Cincinnati, Ohio, 45242, United States

Location

MeSH Terms

Conditions

Cataract

Condition Hierarchy (Ancestors)

Lens DiseasesEye Diseases

Study Officials

  • Michael E. Snyder, MD

    Cincinnati Eye Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 5, 2012

First Posted

March 12, 2012

Study Start

January 1, 2012

Primary Completion

March 1, 2012

Study Completion

March 1, 2012

Last Updated

August 1, 2012

Record last verified: 2012-07

Locations